Corrigendum to: Gastrointestinal motility problems in critical care: A clinical perspective: GI motility issues in the ICU (Journal of Digestive Diseases, (2014), 15, 7, (335-344), 10.1111/1751-2980.12147);Gastrointestinal motility problems in critical care: A clinical perspective

Journal of Digestive Diseases

Volumn 15, Issue 7, 2014, Pages 335-344

  Aderinto Adike, Abimbola O ^a   Quigley, Eamonn M M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Colonic pseudo obstruction; Critical care; Gastroesophageal reflux; Gastroparesis; Ileus; Intensive care unit

Indexed keywords

17 METHYLNALTREXONE; ALVIMOPAN; ATILMOTIN; BOTULINUM TOXIN; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; GHRELIN; ITOPRIDE; LACTULOSE; LUBIPROSTONE; MACROGOL; METOCLOPRAMIDE; MITEMCINAL; NEOSTIGMINE; PYRIDOSTIGMINE; SULPIRIDE; TEGASEROD;

ABDOMINAL PAIN; ARTICLE; ARTIFICIAL VENTILATION; BLOATING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRITICALLY ILL PATIENT; ENTERIC FEEDING; ESOPHAGUS MOTILITY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY DISORDER; GLUCOSE ABSORPTION; HUMAN; ILEUS; INTENSIVE CARE; INTENSIVE CARE UNIT; LOWER ESOPHAGUS SPHINCTER PRESSURE; NAUSEA; NUTRITIONAL SUPPORT; OGILVIE SYNDROME; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; POSTOPERATIVE ILEUS; PREVALENCE; PRIORITY JOURNAL; SCINTIGRAPHY; STOMACH CONTENT; STOMACH EMPTYING; STOMACH PARESIS; VOMITING; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROPARESIS; PHYSIOLOGY;

CRITICAL CARE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROPARESIS; HUMANS; ILEUS; INTENSIVE CARE UNITS;

EID: 84903905186     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12413     Document Type: Erratum

References (60)

1. Martin B. Prevention of gastrointestinal complications in the critically ill patient. AACN Adv Crit Care 2007; 18: 158-166.
2. Fruhwald S, Kainz J. Effect of ICU interventions on gastrointestinal motility. Curr Opin Crit Care 2010; 16: 159-164.
3. Reintam A, Parm P, Redlich U etal. Gastrointestinal failure in intensive care: a retrospective clinical study in three different intensive care units in Germany and Estonia. BMC Gastroenterol 2006; 6: 19.
4. Madl C, Druml W. Gastrointestinal disorders of the critically ill. Systemic consequences of ileus. Best Pract Res Clin Gastroenterol 2003; 17: 445-456.
5. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920; quiz 1943.
6. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014; 63: 871-880.
7. Boeckxstaens GE, Rohof WO. Pathophysiology of gastroesophageal reflux disease. Gastroenterol Clin North Am 2014; 43: 15-25.
8. Enweluzo C, Aziz F. Gastroparesis: a review of current and emerging treatment options. Clin Exp Gastroenterol 2013; 6: 161-165.
9. Nind G, Chen WH, Protheroe R etal. Mechanisms of gastroesophageal reflux in critically ill mechanically ventilated patients. Gastroenterology 2005; 128: 600-606.
10. Schallom M, Orr J, Metheny N, Pierce J. Gastroesophageal reflux in critically ill patients. Dimens Crit Care Nurs 2013; 32: 69-77.
11. McClave SA, DeMeo MT, DeLegge MH etal. North American Summit on aspiration in the critically ill patient: consensus statement. JPEN J Parenter Enteral Nutr 2002; 26: S80-85.
12. Dennesen P, van der Ven A, Vlasveld M etal. Inadequate salivary flow and poor oral mucosal status in intubated intensive care unit patients. Crit Care Med 2003; 31: 781-786.
13. Heyland DK, Drover JW, MacDonald S, Novak F, Lam M. Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: results of a randomized controlled trial. Crit Care Med 2001; 29: 1495-1501.
14. Wilmer A, Tack J, Frans E etal. Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology 1999; 116: 1293-1299.
15. Jing JY, Huang TC, Wang HQ, Jin JF. Effect of gastric versus post-pyloric feeding on the incidence of pneumonia in critically ill patients: observations from traditional and Bayesian random-effects meta-analysis. Clin Nutr 2013; 32: 8-15.
16. Ho KM, Dobb GJ, Webb SA. A comparison of early gastric and post-pyloric feeding in critically ill patients: a meta-analysis. Intensive Care Med 2006; 32: 639-649.
17. Marik PE, Zaloga GP. Gastric versus post-pyloric feeding: a systematic review. Crit Care 2003; 7: R46-51.
18. Alhazzani W, Almasoud A, Jaeschke R etal. Small bowel feeding and risk of pneumonia in adult critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 2013; 17: R127.
19. Prabhakaran S, Doraiswamy VA, Nagaraja V etal. Nasoenteric tube complications. Scand J Surg 2012; 101: 147-155.
20. Metheny NA, Meert KL, Clouse RE. Complications related to feeding tube placement. Curr Opin Gastroenterol 2007; 23: 178-182.
21. DeLegge MH. Managing gastric residual volumes in the critically ill patient: an update. Curr Opin Clin Nutr Metab Care 2011; 14: 193-196.
22. Revicki DA, Camilleri M, Kuo B etal. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther 2009; 30: 670-680.
23. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L; American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013; 108: 18-37; quiz 38.
24. Chapman MJ, Besanko LK, Burgstad CM etal. Gastric emptying of a liquid nutrient meal in the critically ill: relationship between scintigraphic and carbon breath test measurement. Gut 2011; 60: 1336-1343.
25. Hasler WL. Gastroparesis. Curr Opin Gastroenterol 2012; 28: 621-628.
26. 13C-octanoate breath test in critically ill patients: a comparison with scintigraphy. Intensive Care Med 2013; 39: 1238-1246.
27. Deane AM, Zaknic AV, Summers MJ etal. Intrasubject variability of gastric emptying in the critically ill using a stable isotope breath test. Clin Nutr 2010; 29: 682-686.
28. 13C-octanoic acid breath test. Crit Care Med 2001; 29: 1744-1749.
29. Nguyen NQ, Ng MP, Chapman M, Fraser RJ, Holloway RH. The impact of admission diagnosis on gastric emptying in critically ill patients. Crit Care 2007; 11: R16.
30. Lam SW, Nguyen NQ, Ching K, Chapman M, Fraser RJ, Holloway RH. Gastric feed intolerance is not increased in critically ill patients with type II diabetes mellitus. Intensive Care Med 2007; 33: 1740-1745.
31. Nguyen NQ, Fraser RJ, Bryant LK, Chapman M, Holloway RH. Proximal gastric motility in critically ill patients with type 2 diabetes mellitus. World J Gastroenterol 2007; 13: 270-275.
32. Chapman M, Fraser R, Vozzo R etal. Antro-pyloro-duodenal motor responses to gastric and duodenal nutrient in critically ill patients. Gut 2005; 54: 1384-1390.
33. Nguyen NQ, Chapman MJ, Fraser RJ, Bryant LK, Holloway RH. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med 2007; 35: 483-489.
34. Moshiree B, McDonald R, Hou W, Toskes PP. Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci 2010; 55: 675-683.
35. Deane AM, Fraser RJ, Chapman MJ. Prokinetic drugs for feed intolerance in critical illness: current and potential therapies. Crit Care Resusc 2009; 11: 132-143.
36. Chapman MJ, Fraser RJ, Kluger MT, Buist MD, De Nichilo DJ. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Crit Care Med 2000; 28: 2334-2337.
37. Deane AM, Wong GL, Horowitz M etal. Randomized double-blind crossover study to determine the effects of erythromycin on small intestinal nutrient absorption and transit in the critically ill. Am J Clin Nutr 2012; 95: 1396-1402.
38. Caddell KA, Martindale R, McClave SA, Miller K. Can the intestinal dysmotility of critical illness be differentiated from postoperative ileus? Curr Gastroenterol Rep 2011; 13: 358-367.
39. Phipps M, Bush JA, Buhrow D etal. Ileus development in the trauma/surgical intensive care unit: a process improvement evaluation. Dimens Crit Care Nurs 2011; 30: 164-168.
40. Bauer AJ, Schwarz NT, Moore BA, Türler A, Kalff JC. Ileus in critical illness: mechanisms and management. Curr Opin Crit Care 2002; 8: 152-157.
41. Cullen JJ, Caropreso DK, Hemann LL, Hinkhouse M, Conklin JL, Ephgrave KS. Pathophysiology of adynamic ileus. Dig Dis Sci 1997; 42: 731-737.
42. Hill LT, Kidson SH, Michell WL. Corticotropin-releasing factor: a possible key to gut dysfunction in the critically ill. Nutrition 2013; 29: 948-952.
43. Thomas J. Opioid-induced bowel dysfunction. J Pain Symptom Manage 2008; 35: 103-113.
44. Fox-Threlkeld JE, Daniel EE, Christinck F, Hruby VJ, Cipris S, Woskowska Z. Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine. J Pharmacol Exp Ther 1994; 268: 689-700.
45. van der Spoel JI, Oudemans-van Straaten HM, Kuiper MA, van Roon EN, Zandstra DF, van der Voort PH. Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial. Crit Care Med 2007; 35: 2726-2731.
46. van Bree SH, Nemethova A, Cailotto C, Gomez-Pinilla PJ, Matteoli G, Boeckxstaens GE. New therapeutic strategies for postoperative ileus. Nat Rev Gastroenterol Hepatol 2012; 9: 675-683.
47. Bungard TJ, Kale-Pradhan PB. Prokinetic agents for the treatment of postoperative ileus in adults: a review of the literature. Pharmacotherapy 1999; 19: 416-423.
48. Traut U, Brügger L, Kunz R etal. Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults. Cochrane Database Syst Rev 2008; (1): CD004930.
49. Jain A, Vargas HD. Advances and challenges in the management of acute colonic pseudo-obstruction (Ogilvie syndrome). Clin Colon Rectal Surg 2012; 25: 37-45.
50. Saunders MD, Kimmey MB. Systematic review: acute colonic pseudo-obstruction. Aliment Pharmacol Ther 2005; 22: 917-925.
51. Quigley EM. Critical care dysmotility: abnormal foregut motor function in the ICU/ITU patient. Gut 2005; 54: 1351-1352; discussion 1384-90.
52. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999; 341: 137-141.
53. O'Dea CJ, Brookes JH, Wattchow DA. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. Colorectal Dis 2010; 12: 540-548.
54. Weinstock LB, Chang AC. Methylnaltrexone for treatment of acute colonic pseudo-obstruction. J Clin Gastroenterol 2011; 45: 883-884.
55. Thomas J, Karver S, Cooney GA etal. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358: 2332-2343.
56. Sgouros SN, Vlachogiannakos J, Vassiliadis K etal. Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut 2006; 55: 638-642.
57. Gebre-Giorgis AA, Roderique EJ, Stewart D, Feldman MJ, Pozez AL. Neostigmine to relieve a suspected colonic pseudo-obstruction in a burn patient: a case-based review of the literature. Eplasty 2013; 13: e1.
58. Quigley EMM. Megacolon and intestinal pseudo-obstruction. In: Hawkey C, Richter J, Bosch J, Garcia-Tsao G, Chan FKL, eds. Textbook of Clinical Gastroenterology and Hepatology, 2nd edn. Oxford: Wiley-Blackwell, 2012; 488-492.
59. Geller A, Petersen BT, Gostout CJ. Endoscopic decompression for acute colonic pseudo-obstruction. Gastrointest Endosc 1996; 44: 144-150.
60. Baraza W, Brown S, McAlindon M, Hurlstone P. Prospective analysis of percutaneous endoscopic colostomy at a tertiary referral centre. Br J Surg 2007; 94: 1415-1420.